Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?

导出原文传递

翻译打印收藏纠错

第一作者： Kahina,Saker

第一单位： Virology laboratory, Institute of Infectious Agents, Laboratory associated with the National Reference Centre for Respiratory Viruses, Hospices Civils of Lyon, F-69317 Lyon Cedex 04, France.

作者： Kahina,Saker ^[1] ; Bruno,Pozzetto ^[2] ; Antonin,Bal ^[1] ; Martine,Valette ^[1] ; Jean Baptiste,Fassier ^[3] ; Carla,Saade ^[4] ; Mary Anne,Trabaud ^[1] ; Sophie,Trouillet-Assant ^[4] ; COVID SER Study Group

作者单位： Virology laboratory, Institute of Infectious Agents, Laboratory associated with the National Reference Centre for Respiratory Viruses, Hospices Civils of Lyon, F-69317 Lyon Cedex 04, France. ^[1] CIRI- International Center of Research in Infectiology, INSERM U1111, CNRS UMR5308, ENS Lyon, Saint-Etienne University, Claude Bernard Lyon 1 University, F-69008 Lyon, France.;Department of Infectious Agents and Hygiene, University Hospital of Saint-Etienne, 42270 Saint-Priest-en-Jarez, France. ^[2] Occupational Health and Medicine Department, Hospices civils of Lyon, F-69317 Lyon cedex 04, Lyon, France. ^[3] Virology laboratory, Institute of Infectious Agents, Laboratory associated with the National Reference Centre for Respiratory Viruses, Hospices Civils of Lyon, F-69317 Lyon Cedex 04, France.;CIRI- International Center of Research in Infectiology, INSERM U1111, CNRS UMR5308, ENS Lyon, Saint-Etienne University, Claude Bernard Lyon 1 University, F-69008 Lyon, France. ^[4]

主题词抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral);人类(Humans);中和试验(Neutralization Tests)

DOI 10.1093/clinchem/hvac085

PMID 35639802

发布时间 2022-07-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交